Trevor Sandoval
This article features branded content from a third party. Opinions in this article do not reflect the opinions and beliefs of Good Morning US.
Trevor Sandoval•
What if your greatest struggle held your greatest gift? That is the central question at the heart of The Gift in Adversity—a powerful and inspiring documentary produced and directed by…
Trevor Sandoval•
In a major policy change that took effect on August 31, 2025, the Defense Health Agency (DHA) ended insurance coverage for a class of widely used weight-loss medications for military…
Trevor Sandoval•
The Craig Jones Invitational 2 (CJI 2), held in Las Vegas on August 30 and 31, 2025, was more than a record-setting grappling tournament. It was a pivotal moment in…
Trevor Sandoval•
Danes Delight brings a fun, unique perspective to understanding and raising Great Danes, with a witty twist from Yeti, the Great Dane himself. If you’re looking for a place to…
Trevor Sandoval•
The U.S. Food and Drug Administration (FDA) has granted approval for the first-ever treatment designed to address a rare eye disease, offering new hope for patients affected by this debilitating…
Trevor Sandoval•
The state of Ohio has opted to temporarily halt its emergency scheduling of kratom compounds, a move praised by advocacy groups and seen as a significant shift toward more measured…
Trevor Sandoval•
In a world where beauty businesses are often left behind in the digital transformation race, Michele Matkovich has emerged as a trailblazer, fusing technology with the artistry of the beauty…
Trevor Sandoval•
MAP offers unique support for people with food allergies, focusing on mental health, education, and holistic care. Living with food allergies is more than just avoiding triggers or taking medication.…
Trevor Sandoval•
Stefan Alischer transformed his medical crisis into Status Alpha, helping elite men achieve peak performance without extreme diets or brutal workouts. The morning Stefan Alischer woke up in a German…
Trevor Sandoval•
On August 25, 2025, IGC Pharma, Inc. announced the expansion of its Phase 2 CALMA clinical trial, a study focused on testing the effectiveness of its investigational compound IGC-AD1 in…
